← Leaderboards
Irina A. Kirpich
University Of Louisville
$5,792,814
Attributed
$5,792,814
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $732.9K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,792,814 · 6
By mechanism
R01$3,394,696 · 2
P50$1,323,926 · 2
P20$692,910 · 1
R21$381,282 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Craig J McClain$36,863,296
- Shirish S Barve$19,574,914
- Zhong-Bin Deng$6,718,989
- Zhanxiang Zhou$11,702,941
- Jason L Hellmann$2,697,371
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelInflammatoryMediatingCytokineAttenuatedPathogenesisAlcoholsIn VitroMonocyteFda ApprovedWhole BloodHepaticLiver InjuryMacrophageAlcoholic Liver DiseasesReceptorPeripheral BloodAlcoholic HepatitisInflammationLiverProductionDietLinoleic AcidsMolecular
Grant awards (20)
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease$408,636
R01 · FY2025 · AA · contact PI
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease$240,541
P50 · FY2025 · AA · contact PI
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease$413,410
R01 · FY2024 · AA · contact PI
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease$245,405
P50 · FY2024 · AA · contact PI
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease$418,049
R01 · FY2023 · AA · contact PI
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease$314,864
P50 · FY2023 · AA · contact PI
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease$422,101
R01 · FY2022 · AA · contact PI
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease$264,780
P50 · FY2022 · AA · contact PI
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease$258,336
P50 · FY2021 · AA · contact PI
The role of dietary unsaturated fat and inflammasome in alcoholic liver disease$346,500
R01 · FY2020 · AA · contact PI
The role of dietary unsaturated fat and inflammasome in alcoholic liver disease$346,500
R01 · FY2019 · AA · contact PI
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease$167,465
P20 · FY2019 · GM · contact PI
The role of dietary unsaturated fat and inflammasome in alcoholic liver disease$346,500
R01 · FY2018 · AA · contact PI
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease$151,923
P20 · FY2018 · GM · contact PI
The role of dietary unsaturated fat and inflammasome in alcoholic liver disease$346,500
R01 · FY2017 · AA · contact PI
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease$188,842
P20 · FY2017 · GM · contact PI
The role of dietary unsaturated fat and inflammasome in alcoholic liver disease$346,500
R01 · FY2016 · AA · contact PI
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease$184,680
P20 · FY2016 · GM · contact PI
Dietary Fat in Ethanol-Induced Intestinal Barrier Dysfunction in ALD$165,657
R21 · FY2013 · AA · contact PI
Dietary Fat in Ethanol-Induced Intestinal Barrier Dysfunction in ALD$215,625
R21 · FY2012 · AA · contact PI